BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1614 related articles for article (PubMed ID: 15034503)

  • 1. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
    Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
    J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
    Olsen EA; Dunlap FE; Funicella T; Koperski JA; Swinehart JM; Tschen EH; Trancik RJ
    J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.
    Olsen EA; Whiting D; Bergfeld W; Miller J; Hordinsky M; Wanser R; Zhang P; Kohut B
    J Am Acad Dermatol; 2007 Nov; 57(5):767-74. PubMed ID: 17761356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women.
    Tsuboi R; Tanaka T; Nishikawa T; Ueki R; Yamada H; Katsuoka K; Ogawa H; Takeda K
    Eur J Dermatol; 2007; 17(1):37-44. PubMed ID: 17324826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution.
    DeVillez RL; Jacobs JP; Szpunar CA; Warner ML
    Arch Dermatol; 1994 Mar; 130(3):303-7. PubMed ID: 8129407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women.
    Blume-Peytavi U; Hillmann K; Dietz E; Canfield D; Garcia Bartels N
    J Am Acad Dermatol; 2011 Dec; 65(6):1126-1134.e2. PubMed ID: 21700360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.
    Blume-Peytavi U; Kunte C; Krisp A; Garcia Bartels N; Ellwanger U; Hoffmann R
    J Dtsch Dermatol Ges; 2007 May; 5(5):391-5. PubMed ID: 17451383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial.
    Shin HS; Won CH; Lee SH; Kwon OS; Kim KH; Eun HC
    Am J Clin Dermatol; 2007; 8(5):285-90. PubMed ID: 17902730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine increases anagen hair growth and thick hairs in Japanese women with female pattern hair loss: a pilot, double-blind, randomized, placebo-controlled trial.
    Oura H; Iino M; Nakazawa Y; Tajima M; Ideta R; Nakaya Y; Arase S; Kishimoto J
    J Dermatol; 2008 Dec; 35(12):763-7. PubMed ID: 19239555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
    Price VH; Roberts JL; Hordinsky M; Olsen EA; Savin R; Bergfeld W; Fiedler V; Lucky A; Whiting DA; Pappas F; Culbertson J; Kotey P; Meehan A; Waldstreicher J
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):768-76. PubMed ID: 11050579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata.
    Olsen EA; Carson SC; Turney EA
    Arch Dermatol; 1992 Nov; 128(11):1467-73. PubMed ID: 1444500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study.
    Eun HC; Kwon OS; Yeon JH; Shin HS; Kim BY; Ro BI; Cho HK; Sim WY; Lew BL; Lee WS; Park HY; Hong SP; Ji JH
    J Am Acad Dermatol; 2010 Aug; 63(2):252-8. PubMed ID: 20605255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of topical minoxidil therapy for androgenetic alopecia in women.
    Jacobs JP; Szpunar CA; Warner ML
    Int J Dermatol; 1993 Oct; 32(10):758-62. PubMed ID: 8225725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
    Arca E; Açikgöz G; Taştan HB; Köse O; Kurumlu Z
    Dermatology; 2004; 209(2):117-25. PubMed ID: 15316165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of hair loss in men with androgenetic alopecia (male pattern hair loss): long-term (5-year) controlled observational data in placebo-treated patients.
    Kaufman KD; Girman CJ; Round EM; Johnson-Levonas AO; Shah AK; Rotonda J
    Eur J Dermatol; 2008; 18(4):407-11. PubMed ID: 18573713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical minoxidil therapy for androgenetic alopecia. A 30-month study.
    Koperski JA; Orenberg EK; Wilkinson DI
    Arch Dermatol; 1987 Nov; 123(11):1483-7. PubMed ID: 3314717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of minoxidil in chemotherapy-induced alopecia.
    Duvic M; Lemak NA; Valero V; Hymes SR; Farmer KL; Hortobagyi GN; Trancik RJ; Bandstra BA; Compton LD
    J Am Acad Dermatol; 1996 Jul; 35(1):74-8. PubMed ID: 8682968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.
    Blume-Peytavi U; Issiakhem Z; Gautier S; Kottner J; Wigger-Alberti W; Fischer T; Hoffmann R; Tonner F; Bouroubi A; Voisard JJ
    J Cosmet Dermatol; 2019 Feb; 18(1):215-220. PubMed ID: 29659116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
    Gassmueller J; Hoffmann R; Webster A
    Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of a novel treatment for androgenetic alopecia using enriched cell culture medium: clinical trials.
    Lindenbaum ES; Feitelberg AL; Tendler M; Beach D; Gamliel-Lazarovich A; Har-Shai Y; Hirshowitz B
    Dermatol Online J; 2003 Feb; 9(1):4. PubMed ID: 12639462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 81.